Biolegend, 141711, Alexa Fluor® 647 anti-mouse CD206 (MMR) Antibody
25microg
Catalog Number: 141711
Send an RFQ.
Category
| Verified Reactivity | Mouse |
|---|---|
| Antibody Type | Monoclonal |
| Host Species | Rat |
| Immunogen | Recombinant mouse CD206 (MMR) |
| Formulation | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide. |
| Preparation | The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 647 under optimal conditions. |
| Concentration | 0.5 mg/mL |
| Storage & Handling | The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze. |
| Application | ICFC - Quality tested FC, IHC-F - Verified |
| Recommended Usage | Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.5 µg per million cells in 100 µL volume. For immunohistochemistry on frozen tissue sections, a concentration range of 2.5 - 5.0 µg/mL is suggested. It is recommended that the reagent be titrated for optimal performance for each application. * Alexa Fluor® 647 has a maximum emission of 668 nm when it is excited at 633 nm / 635 nm. Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.View full statement regarding label licenses |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Excitation Laser | Red Laser (633 nm) |
|---|
| Application Notes | Clone C068C2 recognizes a region similar to clone MR5D3, based on the ability of the clones to block each other. Additional reported applications (for the relevant formats) include: spatial biology (IBEX)4,5. |
|---|
| Application References(PubMed link indicates BioLegend citation) | Keller J, et al. 2012. Biochem Biophys Res Commun. 417:217. PubMed Ito H, et al. 2012. J Am Soc Nephrol. 23:1797. PubMed Yang X, et al. 2015. PNAS. 112:2900. PubMed Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed |
|---|
| Product Citations | Kretschmer I, et al. 2016. J Biol Chem. 291: 4091 - 4106. PubMed Barkaway A, et al. 2021. Immunity. . PubMed Chandran S, et al. 2020. Front Immunol. 11:787. PubMed Mizutani T, et al. 2023. iScience. 26:106081. PubMed Cheong LY, et al. 2023. Nat Commun. 14:1213. PubMed Vanneste D, et al. 2023. Nat Immunol. 24:827. PubMed Graça FA, et al. 2023. Nat Commun. 14:2900. PubMed El-Naccache DW, et al. 2022. Cell Rep. 40:111150. PubMed Draijer C, et al. 2023. Front Immunol. 13:1056477. PubMed García-García A, et al. 2023. Bioact Mater. 24:174. PubMed Deville S, et al. 2022. Int J Mol Sci. 24: . PubMed Yang L, et al. 2023. Sci Rep. 13:1827. PubMed Chen K, et al. 2022. Adv Sci (Weinh). 9:e2104106. PubMed Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed Song Y, et al. 2013. Eur J Pharmacol. 705:49. PubMed Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed Hu HJ, et al. 2020. Cell Death Dis. 1.168055556. PubMed Kim YS, et al. 2021. Cell Death Dis. 12:307. PubMed Tang E, et al. 2015. J Lipid Res. 56:358. PubMed Schmidleithner L et al. 2019. Immunity. 50(5):1232-1248 . PubMed Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed Helsley RN, et al. 2020. eLife. 8:e49882.. PubMed Chen L, et al. 2020. J Exp Med. 217:00:00. PubMed Calvo-Barreiro L, et al. 2021. Neurotherapeutics. . PubMed Brykczynska U, et al. 2020. Cell Reports. 30(5):1627-1643.e7.. PubMed Sato H, et al. 2020. Cell Reports. 31(5):107579. PubMed Howell KL, et al. 2021. FASEB J. 35:e21618. PubMed Xu Z, et al. 2022. Int J Mol Sci. 23:. PubMed Keller J, et al. 2012. Biochem Biophys Res Commun. 417:217. PubMed Enam SF, et al. 2020. J Neuroinflammation. 0.845138889. PubMed Kumaran Satyanarayanan S, et al. 2019. Nat Commun. 10:3471. PubMed Lee DY, et al. 2020. Chonnam Med J. 56:12:00. PubMed Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed Guo P, et al. 2021. J Immunol. 207:408. PubMed Zhang C, et al. 2022. Nat Commun. 13:3468. PubMed De Simone G, et al. 2021. Immunity. :. PubMed Garre JM, et al. 2020. Nat Commun. 11:1784. PubMed Herrada AA, et al. 2022. Front Immunol. 13:841641. PubMed Blriot C, et al. 2021. Immunity. :. PubMed Ren Y, et al. 2020. Stem Cell Res Ther. 0.743055556. PubMed Wang H, et al. 2016. PLoS One. 11:e0167307. PubMed Li H, et al. 2022. Gut Microbes. 14:2127456. PubMed Carestia A, et al. 2019. Cell Rep. 28:896. PubMed Yu H, et al. 2021. Front Oncol. 11:736882. PubMed Hightower RM, et al. 2019. Mol Ther. 28:189. PubMed Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed Mohammadi MR, et al. 2021. Commun Biol. 4:685. PubMed Ito H, et al. 2012. J Am Soc Nephrol. 23:1797. PubMed He S, et al. 2021. Front Pharmacol. 12:743837. PubMed Zhu Q, et al. 2022. Atherosclerosis. 357:41. PubMed Roux C, et al. 2021. Antioxidants (Basel). 10:. PubMed Put S, et al. 2013. J Nucl Med. 54:807. PubMed Gao L, et al. 2021. Exp Ther Med. 22:1367. PubMed Budhu S, et al. 2021. Cell Reports. 34(2):108620. PubMed Silva HM, et al. 2019. J Exp Med. 216:786. PubMed Chryplewicz A, et al. 2022. Cancer Cell. 40:1111. PubMed Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed Eixarch H, et al. 2020. Neurotherapeutics. 17:1988. PubMed Li H, et al. 2018. Nat Commun. 9:272. PubMed Wang L, et al. 2020. J Nanobiotechnology. 18:38. PubMed De Micheli AJ, et al. 2020. Am J Physiol Cell Physiol. 319:C885. PubMed Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed Chakraborty A, et al. 2021. Biomaterials. 273:120796. PubMed |
|---|
| RRID | AB_10900240 (BioLegend Cat. No. 141711) AB_10900420 (BioLegend Cat. No. 141712) |
|---|
| Structure | Type I transmembrane protein, 175 kD, C-type lectin superfamily |
|---|
| Distribution | Macrophages, dendritic cells, Langerhans cells, liver endothelial cells |
|---|
| Function | Pathogen recognition, endocytosis and phagocytosis, antigen presentation |
|---|
| Ligand/Receptor | Antigen containing mannose, fucose, or an N-acetyl glucosamine |
|---|
| Cell Type | Dendritic cells, Endothelial cells, Langerhans cells, Macrophages |
|---|
| Biology Area | Cell Biology, Immunology, Innate Immunity, Signal Transduction |
|---|
| Molecular Family | CD Molecules |
|---|
| Antigen References | 1. Wileman TE, et al. 1986. P. Natl. Acad. Sci. USA 83:2501. 2. Apostolopoulos V, et al. 2001. Curr. Mol. Med. 1:469. 3. Burgdorf S, et al. 2006. J. Immunol. 176:6770. 4. McKenzie EJ, et al. 2007. J. Immunol. 178:4975. |
|---|
| Gene ID | 17533 |
|---|
| UniProt | View information about CD206 on UniProt.org |
|---|
| Clone | C068C2 |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | MMR (macrophage mannose receptor), MR (mannose receptor), MRC1 |
|---|
| Isotype | Rat IgG2a, κ |
|---|